conivaptan has been researched along with Acute Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barve, A; Elkayam, U; Goldsmith, SR; Haught, WH; He, W | 1 |
| Filippatos, G; Parissis, JT | 1 |
| Singh, M; Slawsky, MT; Valania, G | 1 |
1 review(s) available for conivaptan and Acute Disease
| Article | Year |
|---|---|
Targeting hyponatremia and hemodynamics in acute decompensated heart failure: is there a role for vasopressin antagonists?
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Clinical Trials as Topic; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Pyrroles; Tolvaptan; Vasoconstriction; Vasopressins | 2011 |
1 trial(s) available for conivaptan and Acute Disease
| Article | Year |
|---|---|
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study.
Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Disease Progression; Diuresis; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pain Measurement; Pilot Projects; Receptors, Vasopressin; Vasopressins | 2008 |
1 other study(ies) available for conivaptan and Acute Disease
| Article | Year |
|---|---|
Vasopressin antagonists for the treatment of acute decompensated heart failure: when, for whom, for how long, and on what standard therapy?
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuresis; Heart Failure; Humans; Receptors, Vasopressin; Vasopressins | 2008 |